Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients

Vascular Medicine

Volumn 11, Issue 4, 2006, Pages 245-250

  Nazratun, N ^a   Mahmood, A A ^a   Kuppusamy, Umah Rani ^a   Ahmad, T Sara ^a   Tan, S Y ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

AGE; Artery; Diabetes mellitus; ESRD; Pentosidine; Vein

Indexed keywords

ADVANCED GLYCATION END PRODUCT; PENTOSIDINE;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BLOOD VESSEL BIOPSY; CEPHALIC VEIN; COMORBIDITY; CONTROLLED STUDY; DIABETIC ANGIOPATHY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; RADIAL ARTERY; VEIN DISEASE;

ADULT; AGED; ARGININE; BRACHIOCEPHALIC VEINS; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; LYSINE; MALE; MIDDLE AGED; RADIAL ARTERY;

EID: 33947503467     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863x06072202     Document Type: Article

References (21)

1. Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial transplant, 1997; 12: 255-58.
2. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-57.
3. Takaeuchi M, Yanase Y, Malsuura N et al. Immunological detection of a novel advanced glycation end-product. Mol Med 2001; 11: 783-91.
4. Floridi A, Antolini F, Galli F, Fagugli RM, Floridi E, Buocristiani U. Daily hemodialysis improves indices of protein glycation. Nephrol Dial Transplant 2002; 17: 871-78.
5. Izuhara Y, Miyata T, Ueda Y et al. A sensitive and specific ELISA for plasma pentosidine. Nephrol Dial Transplant 1999; 14: 576-80.
6. Tsukahara H, Shibata R, Ohta N et al. High levels or urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress. Metabolism 2003; 52: 1601-605.
7. Suliman ME, Heimburger O, Barany P et al. Plasma pentosidine is associated with inflammation and malnutrition in end stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol 2003; 14: 1614-22.
8. Dawnay A. Renal clearance of glycation adducts: antiglycation defense in uremia and dialysis. Biochem Soc Trans 2003; 31: 1386-89.
9. Makita Z, Radoff S, Rayfield EJ et al. Advanced glycation end-products in patients with diabetic nephropathy. N Eng J Med 1991; 352: 836-42.
10. Bucala R, Vlassara H. Advanced glycation end products in diabetic renal and vascular disease. Am J Kidney Dis 1995; 26: 875-88.
11. Kuppusamy UR, Indran M, Tsara A, Wong SW, Tan SY, Mahmood AA. Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus. Clin Chim Acta 2005; 351: 197-201.
12. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Eng J Med 1988; 318: 1315-21.
13. Stein G, Frank S, Mahiout A et al. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients. Nephrol Dial Transplant 2001; 16: 999-1008.
14. Miyata T, Kurokawa K, van Ypersele de Strihou C. Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 2000; 11: 1744-52.
15. Tokgoz H, Onaran M, Senocak C, Polat F, Sert S. Temporary vascular access via the external iliac vein as a salvage procedure: a report of two cases. J Vasc Access 2005; 6: 200-202.
16. Brophy DF, Martin RJ, Gehr TWB, Carr ME. A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease. Thromb J 2005; 3: 3-9.
17. Obrenovich ME, Monnier VM. Glycation stimulates amyloid formation. Sci Aging Knowledge Environ 2004; 2: pe3.
18. Miyata T, Oda O, Inagi R et al. β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243-52.
19. Beisswenger PJ, Moore LL, Brinck-Johnssen T, Churpey TJ. Increased collagen-linked pentosidine levels and advanced glycation end products in early diabetic nephropathy. J Clin Invest 1993; 92: 212-17.
20. Kislinger T, Fu C, Huber B et al. N-̇(Carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulated gene expression. J Biol Chem 1999; 274: 31 740-49.
21. Yonekura H, Yamamoto Y, Sakurai S et al. Novel splice variants of the receptor for advanced glycation end-products and expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003; 370: 1097-109.